Loading...
•
Dec 31, 2021
AptarGroup Q4 2021 Earnings Report
AptarGroup's Q4 2021 earnings report indicated revenue growth and adjusted EPS increase.
Key Takeaways
AptarGroup reported a 9% increase in sales, reaching $814 million, with core sales up 10%. Earnings per share increased by 8% to $0.85, and adjusted earnings per share rose by 3% to $0.93. Net income increased by 8% to $58 million.
Strong top line growth across each segment resulted in reported sales up 9% and core sales up 10%.
Reported earnings per share increased 8% to $0.85.
Adjusted earnings per share increased 3% to $0.93.
Reported net income increased 8% to $58 million.
Revenue by Segment
Forward Guidance
Aptar expects solid growth in the Pharma segment and continued recovery in the beauty and beverage businesses. Supply chain disruptions and currency headwinds are expected to continue in the near-term. The company expects earnings per share for the first quarter of 2022 to be in the range of $0.92 to $1.00.
Positive Outlook
- Solid growth expected in Pharma segment.
- Prescription division expected to report growth in the allergy category.
- Active material solutions demand for in-home COVID-19 antigen tests should be strong.
- Beauty business continues to recover, especially in the prestige area.
- Beverage business seeing signs of recovery.
Challenges Ahead
- Other COVID-19 variants may impact the pace of recoveries.
- Supply chain disruptions are expected to continue in the near-term, primarily impacting our business in the U.S.
- Currency headwinds may also continue in the near-term.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...